Selena Simmons-Duffin

Selena Simmons-Duffin reports on health policy for NPR.

She has worked at NPR for ten years as a show editor and producer, with one stopover at WAMU in 2017 as part of a staff exchange. For four months, she reported local Washington, DC, health stories, including a secretive maternity ward closure and a gesundheit machine.

Before coming to All Things Considered in 2016, Simmons-Duffin spent six years on Morning Edition working shifts at all hours and directing the show. She also drove the full length of the U.S.-Mexico border in 2014 for the "Borderland" series.

She won a Gracie Award in 2015 for creating a video called "Talking While Female," and a 2014 AAAS Kavli Science Journalism Award for producing a series on why you should love your microbes.

Simmons-Duffin attended Stanford University, where she majored in English. She took time off from college to do HIV/AIDS-related work in East Africa. She started out in radio at Stanford's radio station, KZSU, and went on to study documentary radio at the Salt Institute, before coming to NPR as an intern in 2009.

She lives in Washington, DC, with her spouse and kids.

Peter Grinspoon got addicted to Vicodin in medical school, and still had an opioid addiction five years into practice as a primary care physician.

Then, in February 2005, he got caught.

Lost in all the brouhaha about President Trump's scuttled plan to buy Greenland from Denmark has been this: What do the Greenlandic people think about the whole thing?

In the small capital city of Nuuk, "everybody is talking about it," says Alexander Montgomery-Andersen, a 30-year-old Greenlandic dancer and choreographer. "It's a little comical."

Good news came out from the Centers for Disease Control and Prevention Wednesday: Preliminary data shows reported drug overdoses declined 4.2% in 2018, after rising precipitously for decades.

High drug prices are a hot topic in politics right now. President Trump has made lowering them a cornerstone of his re-election bid and is pushing a variety of ideas to get that done.

The Trump administration has dropped one of the meatiest portions of its plan to reduce drug prices.

The Department of Health and Human Services said it will no longer pursue a rule that would have prohibited the payment of certain rebates on drugs in Medicare Part D and Medicaid plans.

The idea was to target the middlemen, pharmacy benefit managers, whose negotiations with drugmakers and insurers influence the costs consumers pay for drugs.

Pages